Miral H1 2024 net profit up 8% to SAR 6.5M

27/08/2024 Argaam Exclusive

View other reports

Miral Dental Clinics Co. posted SAR 6.5 million in net profit for H1 2024, a rise of 8% from SAR 6.1 million a year ago.



Financials (M)

Item 6m 2023 6m 2024 Change‬
Revenues 30.70 33.98 10.7 %
Net Income 6.06 6.54 7.9 %
Average Shares 2.00 2.00 -
EPS (Riyals) 3.03 3.27 7.9 %


The annual profit growth was driven by the 11% year-on-year (YoY) revenue hike to SAR 3.28 million on the expanded number of clinics in the Al-Malqa branch and the higher doctor count at the main branches of Al-Tahlia and Al-Malqa districts.

 

Shareholders' equity (no minority interest) climbed to SAR 49.42 million, compared to SAR 36.65 million in H1 2023.

 

Historical Data

Period

Revenue

(SAR mln)

Net Profit

(SAR mln)

EPS

(SAR)

H1 2022

26.52

5.27

2.64

H2 2022

31.94

5.97

2.98

H1 2023

30.70

6.06

3.03

H2 2023

34.67

5.91

2.95

H1 2024

33.97

6.54

3.27
 

 

View More Financial Results

 


Financial results (Million)

Period Revenues Change Gross Income Change Operating Income Change
Q1 2015 - - - - - -
Q2 2015 - - - - - -
Q3 2015 - - - - - -
Q4 2015 - - - - - -
Q1 2016 - - - - - -
Q2 2016 - - - - - -
Q3 2016 - - - - - -
Q4 2016 - - - - - -
Q1 2017 - - - - - -
Q2 2017 - - - - - -
Q3 2017 - - - - - -
Q4 2017 - - - - - -
Q1 2018 - - - - - -
Q2 2018 - - - - - -
Q3 2018 - - - - - -
Q4 2018 - - - - - -
Q1 2019 - - - - - -
Q2 2019 - - - - - -
Q3 2019 - - - - - -
Q4 2019 - - - - - -
Q1 2020 - - - - - -
Q2 2020 - - - - - -
Q3 2020 - - - - - -
Q4 2020 - - - - - -
Q1 2021 - - - - - -
Q2 2021 - - - - - -
Q3 2021 - - - - - -
Q4 2021 - - - - - -
Q1 2022 - - - - - -
Q2 2022 - - - - - -
Q3 2022 15.14 - 5.39 - 3.71 -
Q4 2022 16.80 - 6.42 - 3.76 -
Q1 2023 - - - - - -
Q2 2023 - - - - - -
Q3 2023 17.19 13.5 % 6.31 17.2 % 3.15 (15.1 %)
Q4 2023 17.47 4.0 % 6.60 2.8 % 2.87 (23.6 %)
Q1 2024 - - - - - -
Q2 2024 - - - - - -


Profit Performance (Million)

Period Net Income Change EPS(Riyal) Extraordinary Income/Expense Net Profit Before Unusual Items EPS Before XO Items
Q1 2015 - - - - - -
Q2 2015 - - - - - -
Q3 2015 - - - - - -
Q4 2015 - - - - - -
Q1 2016 - - - - - -
Q2 2016 - - - - - -
Q3 2016 - - - - - -
Q4 2016 - - - - - -
Q1 2017 - - - - - -
Q2 2017 - - - - - -
Q3 2017 - - - - - -
Q4 2017 - - - - - -
Q1 2018 - - - - - -
Q2 2018 - - - - - -
Q3 2018 - - - - - -
Q4 2018 - - - - - -
Q1 2019 - - - - - -
Q2 2019 - - - - - -
Q3 2019 - - - - - -
Q4 2019 - - - - - -
Q1 2020 - - - - - -
Q2 2020 - - - - - -
Q3 2020 - - - - - -
Q4 2020 - - - - - -
Q1 2021 - - - - - -
Q2 2021 - - - - - -
Q3 2021 - - - - - -
Q4 2021 - - - - - -
Q1 2022 - - - - - -
Q2 2022 - - - - - -
Q3 2022 3.40 - 1.70 - 3.40 1.70
Q4 2022 2.56 - 1.28 (0.84) 3.40 1.70
Q1 2023 - - - - - -
Q2 2023 - - - - - -
Q3 2023 2.80 (17.7 %) 1.40 - 2.80 1.40
Q4 2023 2.55 (0.5 %) 1.27 - 2.55 1.27
Q1 2024 - - - - - -
Q2 2024 - - - - - -

Profitability

Period Gross Margin OIBDA Margin Net Margin Before Unusual Items
Q1 2015 - - -
Q2 2015 - - -
Q3 2015 - - -
Q4 2015 - - -
Q1 2016 - - -
Q2 2016 - - -
Q3 2016 - - -
Q4 2016 - - -
Q1 2017 - - -
Q2 2017 - - -
Q3 2017 - - -
Q4 2017 - - -
Q1 2018 - - -
Q2 2018 - - -
Q3 2018 - - -
Q4 2018 - - -
Q1 2019 - - -
Q2 2019 - - -
Q3 2019 - - -
Q4 2019 - - -
Q1 2020 - - -
Q2 2020 - - -
Q3 2020 - - -
Q4 2020 - - -
Q1 2021 - - -
Q2 2021 - - -
Q3 2021 - - -
Q4 2021 - - -
Q1 2022 - - -
Q2 2022 - - -
Q3 2022 35.57 % - 22.47 %
Q4 2022 36.96 % 26.91 % 21.31 %
Q1 2023 - - -
Q2 2023 - - -
Q3 2023 36.87 % - 19.55 %
Q4 2023 37.11 % 23.70 % 18.25 %
Q1 2024 - - -
Q2 2024 - - -


Per Share Data (Riyal)

Compared With The
Period Shares Outstanding (M) EPS (Riyal) Adjusted EPS (Riyal) Book Value (BV)
Q1 2015 - - - -
Q2 2015 - - - -
Q3 2015 - - - -
Q4 2015 - - - -
Q1 2016 - - - -
Q2 2016 - - - -
Q3 2016 - - - -
Q4 2016 - - - -
Q1 2017 - - - -
Q2 2017 - - - -
Q3 2017 - - - -
Q4 2017 - - - -
Q1 2018 - - - -
Q2 2018 - - - -
Q3 2018 - - - -
Q4 2018 - - - -
Q1 2019 - - - -
Q2 2019 - - - -
Q3 2019 - - - -
Q4 2019 - - - -
Q1 2020 - - - -
Q2 2020 - - - -
Q3 2020 - - - -
Q4 2020 - - - -
Q1 2021 - - - -
Q2 2021 - - - -
Q3 2021 - - - -
Q4 2021 - - - -
Q1 2022 - - - -
Q2 2022 - - - -
Q3 2022 2.00 1.70 1.70 13.30
Q4 2022 2.00 2.98 3.40 15.02
Q1 2023 - - - -
Q2 2023 - - - -
Q3 2023 2.00 4.38 4.80 19.54
Q4 2023 2.00 5.66 6.08 20.97
Q1 2024 - - - -
Q2 2024 - - - -

Multiple Ratios (End of Period Price)

Compared With The
Period P/E Adjusted P/E Price/book
Q1 2015 - - -
Q2 2015 - - -
Q3 2015 - - -
Q4 2015 - - -
Q1 2016 - - -
Q2 2016 - - -
Q3 2016 - - -
Q4 2016 - - -
Q1 2017 - - -
Q2 2017 - - -
Q3 2017 - - -
Q4 2017 - - -
Q1 2018 - - -
Q2 2018 - - -
Q3 2018 - - -
Q4 2018 - - -
Q1 2019 - - -
Q2 2019 - - -
Q3 2019 - - -
Q4 2019 - - -
Q1 2020 - - -
Q2 2020 - - -
Q3 2020 - - -
Q4 2020 - - -
Q1 2021 - - -
Q2 2021 - - -
Q3 2021 - - -
Q4 2021 - - -
Q1 2022 - - -
Q2 2022 - - -
Q3 2022 - - -
Q4 2022 - - -
Q1 2023 - - -
Q2 2023 - - -
Q3 2023 - - -
Q4 2023 - - -
Q1 2024 - - -
Q2 2024 - - -

Business Segments (Million)

Compared With The
Period Revenue from individuals Revenue from insurance companies
Q3 2022 5.71 9.43
Q4 2022 10.76 6.04
Q3 2023 7.01 10.18
Q4 2023 10.36 7.11


Financial Ratios
Current
Market Cap (M Riyal) 170.80
Enterprise Value (EV) (M) 145.36
Shares Outstanding ((M)) 2.00
Book Value (BV) ( Riyal) 20.97
Par Value ( Riyal) 10.00
Adjusted P/E (Last12) 14.27
Price/book 4.07
more

Share Price

Miral Dental Clinics Co.
85.40
(1.10) (1.27 %)

Miral Dental Clinics Co. (MIRAL)

More

Comments {{getCommentCount()}}

Be the first to comment

{{Comments.indexOf(comment)+1}}
{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
loader Train
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.